Ifp Advisors, Inc Intra Cellular Therapies, Inc. Transaction History

Ifp Advisors, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 30, 2024	BUY	$64.37 - $75.65 $1,094 - $1,286	17 New	17 $1,000
Q2 2023 Aug 04, 2023	BUY	$54.67 - $66.44 $1,038 - $1,262	19 New	19 $1,000
Q3 2022 Nov 08, 2022	SELL	$42.7 - $59.99 $8,540 - $11,998	-200 Reduced 33.28%	401 $10,000
Q2 2022 Sep 06, 2022	BUY	$43.0 - $65.64 $25,843 - $39,449	601 New	601 $15,000
Q2 2022 Aug 12, 2022	SELL	$43.0 - $65.64 $25,843 - $39,449	-601 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$38.74 - $62.09 $23,282 - $37,316	601 New	601 $36,000
Q3 2017 Oct 30, 2017	SELL	$10.77 - $22.1 $3,231 - $6,630	-300 Closed	0 $0
Q4 2016 Jun 03, 2019	SELL	N/A	-200 Reduced 40.0%	300 $5,000
Q2 2016 Jun 03, 2019	BUY	N/A	500	500 $19,000

378

84.1M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.9B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.